Prolyl hydroxylase domain enzyme 2 is the major player in regulating hypoxic responses in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 64, Issue 9, 2012, Pages 2856-2867

  Muz, Barbara ^a   Larsen, Helene ^b   Madden, Leigh ^b   Kiriakidis, Serafim ^b   Paleolog, Ewa M ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE IX; EPHRIN A3; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; SMALL INTERFERING RNA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL LEVEL; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; SUPERNATANT; SYNOVIOCYTE; UPREGULATION; WESTERN BLOTTING;

ARTHRITIS, RHEUMATOID; CELL HYPOXIA; CELLS, CULTURED; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOVASCULARIZATION, PATHOLOGIC; PROCOLLAGEN-PROLINE DIOXYGENASE; SYNOVIAL MEMBRANE;

EID: 84865660860     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34479     Document Type: Article

References (45)

1. Lefevre S, Knedla A, Tennie C, Kampmann A, Wunrau C, Dinser R, et al. Synovial fibroblasts spread rheumatoid arthritis to unaffected joints. Nat Med 2009; 15: 1414-20.
2. Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996; 149: 1607-15.
3. Sivakumar B, Akhavani MA, Winlove CP, Taylor PC, Paleolog EM, Kang N,. Synovial hypoxia as a cause of tendon rupture in rheumatoid arthritis. J Hand Surg Am 2008; 33: 49-58.
4. Berse B, Hunt JA, Diegel RJ, Morganelli P, Yeo K, Brown F, et al. Hypoxia augments cytokine (transforming growth factor-β (TGF-β) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol 1999; 115: 176-82.
5. Del Rey MJ, Izquierdo E, Caja S, Usategui A, Santiago B, Galindo M, et al. Human inflammatory synovial fibroblasts induce enhanced myeloid cell recruitment and angiogenesis through a hypoxia-inducible transcription factor 1α/vascular endothelial growth factor-mediated pathway in immunodeficient mice. Arthritis Rheum 2009; 60: 2926-34.
6. Paleolog EM, Young S, Stark AC, McCloskey RV, Feldmann M, Maini RN,. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor α and interleukin-1 in rheumatoid arthritis. Arthritis Rheum 1998; 41: 1258-65.
7. Kennedy A, Ng CT, Biniecka M, Saber T, Taylor C, O'Sullivan J, et al. Angiogenesis and blood vessel stability in inflammatory arthritis. Arthritis Rheum 2010; 62: 711-21.
8. Izquierdo E, Canete JD, Celis R, Santiago B, Usategui A, Sanmarti R, et al. Immature blood vessels in rheumatoid synovium are selectively depleted in response to anti-TNF therapy. PLoS One 2009; 4: e8131.
9. Huang LE, Arany Z, Livingston DM, Bunn HF,. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit. J Biol Chem 1996; 271: 32253-9.
10. Semenza GL, Wang GL,. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992; 12: 5447-54.
11. Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, Fujii-Kuriyama Y,. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci U S A 1997; 94: 4273-8.
12. Tian H, McKnight SL, Russell DW,. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 1997; 11: 72-82.
13. Gu YZ, Moran SM, Hogenesch JB, Wartman L, Bradfield CA,. Molecular characterization and chromosomal localization of a third α-class hypoxia inducible factor subunit, HIF3α. Gene Expr 1998; 7: 205-13.
14. Wang GL, Semenza GL,. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 1995; 270: 1230-7.
15. Bruick RK, McKnight SL,. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001; 294: 1337-40.
16. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001; 107: 43-54.
17. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-5.
18. 2 sensing. Science 2001; 292: 464-8.
19. McNeill LA, Hewitson KS, Claridge TD, Seibel JF, Horsfall LE, Schofield CJ,. Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the β-carbon of asparagine-803. Biochem J 2002; 367: 571-5.
20. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML,. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 2002; 295: 858-61.
21. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
22. Brennan FM, Chantry D, Jackson AM, Maini RN, Feldmann M,. Cytokine production in culture by cells isolated from the synovial membrane. J Autoimmun 1989; 2 Suppl: 177-86.
23. Larsen H, Muz B, Khong TL, Feldmann M, Paleolog EM,. Differential effects of Th1 versus Th2 cytokines in combination with hypoxia on HIFs and angiogenesis in RA. Submitted for publication.
24. Lund-Olesen K,. Oxygen tension in synovial fluids. Arthritis Rheum 1970; 13: 769-76.
25. 2-regulated prolyl hydroxylation. Science 2001; 292: 468-72.
26. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK,. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 2002; 16: 1466-71.
27. Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J,. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J 2003; 22: 4082-90.
28. Vengellur A, Woods BG, Ryan HE, Johnson RS, LaPres JJ,. Gene expression profiling of the hypoxia signaling pathway in hypoxia-inducible factor 1α null mouse embryonic fibroblasts. Gene Expr 2003; 11: 181-97.
29. Appelhoff RJ, Tian YM, Raval RR, Turley H, Harris AL, Pugh CW, et al. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 2004; 279: 38458-65.
30. Koivunen P, Hirsila M, Gunzler V, Kivirikko KI, Myllyharju J,. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J Biol Chem 2004; 279: 9899-904.
31. Willam C, Maxwell PH, Nichols L, Lygate C, Tian YM, Bernhardt W, et al. HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation. J Mol Cell Cardiol 2006; 41: 68-77.
32. Nakayama K, Ronai Z,. Siah: new players in the cellular response to hypoxia. Cell Cycle 2004; 3: 1345-7.
33. Takeda K, Ho VC, Takeda H, Duan LJ, Nagy A, Fong GH,. Placental but not heart defects are associated with elevated hypoxia-inducible factor α levels in mice lacking prolyl hydroxylase domain protein 2. Mol Cell Biol 2006; 26: 8336-46.
34. Masson N, Willam C, Maxwell PH, Pugh CW, Ratcliffe PJ,. Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation. EMBO J 2001; 20: 5197-206.
35. Hirsila M, Koivunen P, Gunzler V, Kivirikko KI, Myllyharju J,. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 2003; 278: 30772-80.
36. D'Angelo G, Duplan E, Boyer N, Vigne P, Frelin C,. Hypoxia up-regulates prolyl hydroxylase activity: a feedback mechanism that limits HIF-1 responses during reoxygenation. J Biol Chem 2003; 278: 38183-7.
37. Ginouves A, Ilc K, Macias N, Pouyssegur J, Berra E,. PHDs overactivation during chronic hypoxia "desensitizes" HIFα and protects cells from necrosis. Proc Natl Acad Sci U S A 2008; 105: 4745-50.
38. Huang J, Zhao Q, Mooney SM, Lee FS,. Sequence determinants in hypoxia-inducible factor-1α for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3. J Biol Chem 2002; 277: 39792-800.
39. Mazure NM, Brahimi-Horn MC, Berta MA, Benizri E, Bilton RL, Dayan F, et al. HIF-1: master and commander of the hypoxic world: a pharmacological approach to its regulation by siRNAs. Biochem Pharmacol 2004; 68: 971-80.
40. Thoms BL, Murphy CL,. Inhibition of hypoxia-inducible factor-targeting prolyl hydroxylase domain-containing protein 2 (PHD2) enhances matrix synthesis by human chondrocytes. J Biol Chem 2010; 285: 20472-80.
41. Takeda K, Cowan A, Fong GH,. Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system. Circulation 2007; 116: 774-81.
42. Takeda K, Aguila HL, Parikh NS, Li X, Lamothe K, Duan LJ, et al. Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. Blood 2008; 111: 3229-35.
43. Marxsen JH, Stengel P, Doege K, Heikkinen P, Jokilehto T, Wagner T, et al. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-α-prolyl-4-hydroxylases. Biochem J 2004; 381: 761-7.
44. Pescador N, Cuevas Y, Naranjo S, Alcaide M, Villar D, Landazuri MO, et al. Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem J 2005; 390: 189-97.
45. Giatromanolaki A, Sivridis E, Maltezos E, Athanassou N, Papazoglou D, Gatter KC, et al. Upregulated hypoxia inducible factor-1α and -2α pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 2003; 5: R193-201.